
Investors fret on talk of AstraZeneca US move
Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Investors are warning that if AstraZeneca left London to list in New York, it would be a loss for the entire market and potentially the UK economy. Iain Pyle, a fund manager at Aberdeen, said…